Not Tagged
MiNA Therapeutics
[]
#minatherapeutics presents late-breaking positive phase 1b data for #mtlcebpa in combination with an #antipd1 #checkpointinhibitor at the #aacr23 
Follow top-line development in the oncology commercial domain through our award winning intelligence service, 1stOncology.